Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells

• Published in: Journal of general virology Vol. 81; no. 8; pp. 2017 - 2027
• Main Author: Muggeridge, Martin I
• Format: Journal Article
• Language: English
• Published: England Soc General Microbiol 01.08.2000
• Subjects: Animals; Antibodies, Monoclonal - immunology; COS Cells; Cyclosporine - pharmacology; Herpes simplex virus 2; Herpesvirus 2, Human - physiology; Membrane Fusion; Transfection; Viral Envelope Proteins - physiology
• ISSN: 0022-1317; 1465-2099
• DOI: 10.1099/0022-1317-81-8-2017

Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA 1 Author for correspondence: Martin Muggeridge. Fax +1 318 675 5764. e-mail mmugge{at}lsumc.edu The mechanisms by which herpes simplex viruses (HSV) mediate fusion between their envelope and the plasma membrane during entry into cells, and between the plasma membranes of adjacent infected and uninfected cells to form multinucleated giant cells, are poorly understood. Four viral glycoproteins (gB, gD, gH and gL) are required for virus–cell fusion, whereas these plus several others are required for cell–cell fusion (syncytium formation). A better understanding would be aided by the availability of a model system, whereby fusion could be induced with a minimal set of proteins, in the absence of infection. A suitable system has now been developed for HSV-2, using transfected COS7, 293 or HEp-2 cells. Insofar as the minimal set of HSV-2 proteins required to cause cell–cell fusion in this system is gB, gD, gH and gL, it would appear to resemble virus–cell fusion rather than syncytium formation. However, the ability of a mutation in gB to enhance the fusion of both transfected cells and infected cells, while having no effect on virus–cell fusion, points to the opposite conclusion. The differential effects of a panel of anti-HSV antibodies, and of the fusion-inhibitor cyclosporin A, confirm that the fusion of transfected cells shares some properties with virus–cell fusion and others with syncytium formation. It may therefore prove useful for determining how these processes differ, and for testing the hypothesis that some viral proteins prevent membrane fusion until the appropriate point in the virus life-cycle, with other proteins then overcoming this block.